Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-10-04 5:00 pm Sale | 13D | Augmedix Inc. AUGX | Redmile Group LLC | 0 0% | -22,131,580 (Position Closed) | View |
2024-09-13 4:01 pm Sale | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Redmile Group LLC | 579,541 9.9% | -9,721,868 (-94.37%) | View |
2024-07-19 7:45 pm Purchase | 13D | Augmedix Inc. AUGX | Redmile Group LLC | 22,131,580 40.5% | 39,369 (+0.18%) | View |
2024-03-25 5:15 pm Purchase | 13D | FATE THERAPEUTICS INC FATE | Redmile Group LLC | 17,619,095 14.9% | 2,569,256 (+17.07%) | View |
2024-03-13 5:15 pm Sale | 13D | Science 37 Holdings Inc. SNCE | Redmile Group LLC | 0 0% | -994,529 (Position Closed) | View |
2024-03-05 5:15 pm Purchase | 13D | ABSCI CORP ABSI | Redmile Group LLC | 8,282,016 7.4% | 250,922 (+3.12%) | View |
2024-02-14 4:26 pm Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 15,328,317 18.8% | 1,763,068 (+13.00%) | View |
2024-02-14 4:26 pm Sale | 13G | ALX ONCOLOGY HLDGS INC ALXO | Redmile Group LLC | 4,909,264 9.6% | -82,281 (-1.65%) | View |
2024-02-14 4:26 pm Sale | 13G | Akero Therapeutics Inc. AKRO | Redmile Group LLC | 1,109,476 2% | -1,523,436 (-57.86%) | View |
2024-02-14 4:26 pm Sale | 13G | Entrada Therapeutics Inc. TRDA | Redmile Group LLC | 1,283,735 3.8% | -570,373 (-30.76%) | View |
2024-02-14 4:26 pm Sale | 13G | HOOKIPA PHARMA INC HOOK | Redmile Group LLC | 1,063,769 1.1% | -4,396,999 (-80.52%) | View |
2024-02-14 4:26 pm Sale | 13G | Krystal Biotech Inc. KRYS | Redmile Group LLC | 1,733,189 6.1% | -163,456 (-8.62%) | View |
2024-02-14 4:26 pm Sale | 13G | LAVA THERAPEUTICS N V SHS LVTX | Redmile Group LLC | 2,074,372 7.9% | -741,824 (-26.34%) | View |
2024-02-14 4:26 pm Sale | 13G | PLIANT THERAPEUTICS INC PLRX | Redmile Group LLC | 2,696,648 4.5% | -1,181,951 (-30.47%) | View |
2024-02-14 4:26 pm Sale | 13G | REGENXBIO Inc. RGNX | Redmile Group LLC | 3,760,690 8.6% | -477,622 (-11.27%) | View |
2024-02-14 4:26 pm Sale | 13G | REPARE THERAPEUTICS INC RPTX | Redmile Group LLC | 2,148,748 5.1% | -535,648 (-19.95%) | View |
2024-02-14 4:26 pm Sale | 13G | STEREOTAXIS INC STXS | Redmile Group LLC | 3,402,443 4.2% | -3,695,173 (-52.06%) | View |
2024-02-14 4:26 pm Sale | 13G | Stoke Therapeutics Inc. STOK | Redmile Group LLC | 2,625,506 5.9% | -1,541,469 (-36.99%) | View |
2024-02-14 4:26 pm Sale | 13G | ZYMEWORKS INC ZYME | Redmile Group LLC | 5,790,230 8.3% | -385,688 (-6.25%) | View |
2024-02-14 4:26 pm Purchase | 13G | GRITSTONE BIO INC GRTS | Redmile Group LLC | 10,135,388 9.9% | 1,652,066 (+19.47%) | View |